Plaintiffs Propose “Road Map” For Drug Pricing Suit

Law360, New York (August 3, 2007, 12:00 AM EDT) -- The plaintiffs in the massive antitrust class action alleging a slew of drug makers defrauded consumers by artificially inflating the prices of various prescription medications have presented the court with a "road map" for how best to organize the complex litigation.

The plaintiffs said in court documents filed Thursday that the court should initially focus on three defendants, Sanofi-Aventis, Amgen Inc. and Watson Pharmaceuticals, otherwise known as the “Track 2 defendants,” who made single-source drugs.

The plaintiffs said these defendants and the single-source drugs they manufactured...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.